Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...
SAN DIEGO--(BUSINESS WIRE)--Accumetrics, Inc., developer of the VerifyNow ® System, the first rapid and easy-to-use system for measuring platelet reactivity to multiple antiplatelet agents, announced ...
Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, ...
Patients with High Platelet Reactivity had 2.5 Times Greater Rate of Stent Thrombosis at 1-Year. Miami, FL – Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use ...
Following Stent Placement, Low Platelet Reactivity at Time of Discharge and After 30 Days Leads to 50% Reduction in Cardiovascular Events "These new findings from GRAVITAS demonstrate that patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results